Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (201-210 of 254) with videos related to

Pageof 26
Sort By:
Blood|September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid LeukemiaEmilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Haematologica|January 13, 2022
Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children's Oncology Group studyFieke W Hoff, Anneke D Van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid LeukemiaJason E Farrar, Jenny L Smith, Megan Othus, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
NPJ Precision Oncology|August 1, 2024
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trialsAbdelrahman H Elsayed, Xueyuan Cao, Richard J Marrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology GroupBenjamin J Huang, Lauren K Meyer, Todd A Alonzo, et al.
Research Square|December 23, 2024
Long-read epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaJatinder Lamba, Francisco Marchi, Marieke Landwehr, et al.
Pageof 26

Showing results (201-210 of 254) with videos related to

Sort By:
Pageof 26
Blood|September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid LeukemiaEmilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Haematologica|January 13, 2022
Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children's Oncology Group studyFieke W Hoff, Anneke D Van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid LeukemiaJason E Farrar, Jenny L Smith, Megan Othus, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
NPJ Precision Oncology|August 1, 2024
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trialsAbdelrahman H Elsayed, Xueyuan Cao, Richard J Marrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology GroupBenjamin J Huang, Lauren K Meyer, Todd A Alonzo, et al.
Research Square|December 23, 2024
Long-read epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaJatinder Lamba, Francisco Marchi, Marieke Landwehr, et al.
Pageof 26